Formulation development and characterization of galantamine hydrobromide extended-release capsules (8mg)
Crossref DOI link: https://doi.org/10.30574/ijsra.2023.10.2.1021
Published Online: 2023-12-30
Update policy: https://doi.org/10.30574/ijsra.ourcrossmarkpolicy
Alli Srija,
M. Sunitha Reddy,
K. Hari Krishna,
A. Vijay Reddy,
